Affymax Warns

Affymax Inc. (Nasdaq: AFFY) warned in its 10-Q filing that it may never achieve profitability and may not be able to continue operations if safety concerns over OMONTYS are not rectified by Takeda Pharmaceutical. Shares of the biopharmaceutical plunged 49 cents to $1.32.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here